Prkaca Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| PKA Catalytic Subunit Alpha | |
|---|---|
| Gene Symbol | PRKACA |
| UniProt ID | P17612 |
| PDB ID | 1J3H, 2GU8, 3TNP |
| Molecular Weight | 40.6 kDa |
| Subcellular Localization | Cytosol, nucleus, plasma membrane |
| Protein Family | Protein kinase A (PKA) family, cAMP-dependent protein kinase |
Protein Kinase A (PKA) is a serine/threonine-specific protein kinase that functions as the catalytic subunit of the cAMP-dependent protein kinase (PKA). The PRKACA gene encodes the catalytic subunit Cα (PKA-Cα), which is one of the most important mediators of cAMP signaling in neurons[1]. PKA plays critical roles in synaptic plasticity, memory formation, gene transcription, and neuronal survival, making it a key player in both normal brain function and neurodegenerative disease pathogenesis.
PKA catalytic subunit contains several critical structural domains:
The crystal structure of PKA has been solved in multiple conformations:
The catalytic mechanism involves transfer of the γ-phosphate from ATP to serine/threonine residues on substrate proteins, requiring Mg²⁺ as a cofactor[2].
PKA is activated by the second messenger cAMP, which is produced by adenylyl cyclase in response to neurotransmitter binding:
PKA regulates numerous neuronal processes[3]:
| Function | Target Proteins | Effect |
|---|---|---|
| Synaptic plasticity | GluA1, CREB, DARPP-32 | LTP/LTD modulation |
| Gene transcription | CREB, c-Fos | Long-term changes |
| Ion channel function | HCN, Cav1.2 | Neuronal excitability |
| Metabolism | Glycogen synthase | Energy regulation |
| Cytoskeleton | MAP2, Tau | Dendritic spine morphology |
PKA is enriched in:
PRKACA expression is relatively constant throughout development but shows regional specificity:
PKA signaling is dysregulated in AD brain[4]:
Therapeutic implications: PKA activators (e.g., phosphodiesterase inhibitors) are being explored to enhance memory in AD.
PKA plays complex roles in PD[^5]:
Therapeutic implications: PKA modulators may help manage motor complications.
| Compound | Mechanism | Stage | Indication |
|---|---|---|---|
| Rp-8-CPT-cAMPS | PKA inhibitor | Preclinical | Drug addiction |
| KT5720 | PKA inhibitor | Preclinical | Cancer |
| 8-CPT-2'-O-Me-cAMP | PKA activator | Preclinical | Memory enhancement |
| Forskolin | Adenylyl cyclase activator | Research | Cognitive decline |
The study of Prkaca Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Skalhegg BS, Tasken K (2000). Specificity in the cAMP/PKA signaling pathway. Advances in Second Messenger and Phosphoprotein Research. 33:1-23. 2000. ↩︎
Adams JA, Taylor SS (1992). Divalent metal ions influence catalysis and substrate accessibility in the cAMP-dependent protein kinase. Journal of Biological Chemistry. 267(10):7315-7323. 1992. ↩︎
Wang H, Storm DR (2003). Calmodulin-regulated adenylyl cyclases as computational nodes in neuronal signaling. Cell Calcium. 34(3):239-252. 2003. ↩︎
Noble W, et al. (2005). 2005. ↩︎